Advertisement

Oral Cancer pp 319-333 | Cite as

Chemotherapy

  • Iwai TohnaiEmail author
  • Kenji Mitsudo
Chapter

Abstract

For patients with locally advanced head and neck cancer, including in the oral cavity, surgery with or without radiotherapy is widely accepted as the standard treatment and is thought to be the most effective curative therapy. However, extended surgery causes loss of oral function, including swallowing and speech, and reduces patient’s quality of life. To preserve function while maintaining or improving locoregional control and survival rates, concurrent chemoradiotherapy represents one of the standard treatment modalities for definitive treatment of locoregionally advanced squamous cell carcinoma of the oral cavity, particularly in resectable advanced cases. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy have the advantage of delivering a high concentration of the chemotherapeutic agents to the tumor bed, and they can be used to provide daily concurrent chemoradiotherapy to patients with advanced oral cancer. The treatment results of retrograde superselective intra-arterial chemoradiotherapy for locally advanced oral cancer have been reported to be similar to those of surgery, suggesting the usefulness of this treatment modality.

Oral cancer patients with advanced cervical lymph node metastases have a poor prognosis. Hyperthermia has generally been confined to treatment of cervical lymph node metastases accessible with a radiofrequency system using external application and in combination with synergistic chemoradiotherapy. Thermochemoradiotherapy using retrograde superselective intra-arterial infusion is used in patients with advanced cervical lymph node metastases, and not only the primary lesion but also cervical lymph node metastases are controlled.

In this chapter, the therapeutic results in patients with advanced oral cancer treated with retrograde superselective intra-arterial chemoradiotherapy and the effectiveness of thermochemoradiotherapy for patients with advanced cervical lymph node metastases are described.

Keywords

Chemoradiotherapy Hyperthermia Oral cancer Organ preservation Retrograde superselective intra-arterial infusion 

References

  1. 1.
    Klopp CT, Alford TC, Bateman J et al (1950) Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg 132:811–832CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Sullivan RD, Miller E, Sikes MP (1959) Antimetabolite-metabolite combination cancer chemotherapy. Effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer. Cancer 12:1248–1262CrossRefPubMedGoogle Scholar
  3. 3.
    Ramsden CH, Duff JK (1963) Continuous arterial infusion of head and neck tumors; improvements in technique by retrograde temporal artery catheterization. Cancer 16:133–135CrossRefPubMedGoogle Scholar
  4. 4.
    Burn JI, Johnston ID, Davies AJ et al (1966) Cancer chemotherapy by continuous intra-arterial infusion of methotrexate. Br J Surg 53:329–336CrossRefPubMedGoogle Scholar
  5. 5.
    Bertino JR, Mosher MB, DeConti RC (1973) Chemotherapy of cancer of the head and neck. Cancer 31:1141–1149CrossRefPubMedGoogle Scholar
  6. 6.
    Auersperg M, Furlan L, Marolt F et al (1978) Intra-arterial chemotherapy and radiotherapy in locally advanced cancer of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 4:273–277CrossRefPubMedGoogle Scholar
  7. 7.
    Lee YY, Wallace S, Dimery I et al (1986) Intraarterial chemotherapy of head and neck tumors. Am J Neuroradiol 7:343–348PubMedGoogle Scholar
  8. 8.
    Lee YY, Dimery IW, Van Tassel P et al (1989) Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Head Neck Surg 115:503–511Google Scholar
  9. 9.
    Robbins KT, Storniolo AM, Kerber C et al (1992) Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 14:364–371CrossRefPubMedGoogle Scholar
  10. 10.
    Robbins KT, Storniolo AM, Kerber C et al (1994) Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12:2113–2120PubMedGoogle Scholar
  11. 11.
    Robbins KT, Kumar PV, Regine WF et al (1997) Efficacy of target supradose cisplatin and concurrent radiation therapy for advanced head and neck cancer; the memphis experience. Int J Radiat Oncol Biol Phys 38:263–271CrossRefPubMedGoogle Scholar
  12. 12.
    Ikushima I, Korogi Y, Ishii A et al (2007) Superselective arterial infusion chemotherapy for squamous cell carcinomas of the oral cavity: histopathologic effects on metastatic neck lymph nodes. Eur Arch Otorhinolaryngol 264:269–275CrossRefPubMedGoogle Scholar
  13. 13.
    Sakashita T, Homma A, Oridate N et al (2012) Platinum concentration in sentinel lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting primary tongue cancer. Acta Otolaryngol 132:1121–1125CrossRefPubMedGoogle Scholar
  14. 14.
    Ackerstaff AH, Tan IB, Rasch CR et al (2002) Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 128:1185–1190CrossRefPubMedGoogle Scholar
  15. 15.
    Valentino J, Spring PM, Shane M et al (2002) Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT). Head Neck 24:539–544CrossRefPubMedGoogle Scholar
  16. 16.
    Balm AJ, Rasch CR, Schornagel JH et al (2004) High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 26: 485–493CrossRefPubMedGoogle Scholar
  17. 17.
    Robbins KT, Kumar P, Harris J et al (2005) Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of radiation therapy oncology group trial 9615. J Clin Oncol 23:1447–1454CrossRefPubMedGoogle Scholar
  18. 18.
    Homma A, Oridate N, Suzuki F et al (2009) Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 115:4705–4714CrossRefPubMedGoogle Scholar
  19. 19.
    Kobayashi W, Teh BG, Sakaki H et al (2010) Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer. Oral Oncol 46:860–863CrossRefPubMedGoogle Scholar
  20. 20.
    Kano S, Homma A, Oridate N et al (2011) Superselective arterial cisplatin infusion with concomitant radiation therapy for base of tongue cancer. Oral Oncol 47:665–670CrossRefPubMedGoogle Scholar
  21. 21.
    Rasch CR, Hauptmann M, Schornagel J et al (2010) Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 116:2159–2165CrossRefPubMedGoogle Scholar
  22. 22.
    Robbins KT, Howell SB, Williams JS (2010) Intra-arterial chemotherapy for head and neck cancer: is there a verdict? Cancer 116: 2068–2070CrossRefPubMedGoogle Scholar
  23. 23.
    Hattori T, Hirano T, Toyoda S et al (1985) Superselective intra-arterial chemotherapy via the superficial temporal artery for head and neck tumor. Jpn J Radiol 45:1056–1058Google Scholar
  24. 24.
    Fuwa N, Ito Y, Kato E et al (1996) Superselective intra-arterial continuous chemotherapy with CBDCA for advanced head and neck cancer. Jpn J Head Neck Cancer 22:139–143CrossRefGoogle Scholar
  25. 25.
    Tohnai I, Fuwa N, Hayashi Y et al (1998) New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34:387–390CrossRefPubMedGoogle Scholar
  26. 26.
    Fuwa N, Ito Y, Matsumoto A et al (2000) A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Cancer 89:2099–2105CrossRefPubMedGoogle Scholar
  27. 27.
    Tohnai I (2006) Chemotherapy using intra-arterial infusion for oral cancer. Nagoya J Med Sci 68:101–108PubMedGoogle Scholar
  28. 28.
    Mitsudo K, Shigetomi T, Fujimoto Y et al (2011) Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. Int J Radiat Oncol Biol Phys 79: 1428–1435CrossRefPubMedGoogle Scholar
  29. 29.
    Fuwa N, Kodaira T, Furutani K et al (2008) A new method of selective intra-arterial infusion therapy via the superficial temporal artery for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:783–789CrossRefPubMedGoogle Scholar
  30. 30.
    Iwai T, Fuwa N, Hirota M, et al (2014) Secure surgical method for catheter placement via the occipital artery to achieve retrograde superselective intra-arterial chemotherapy for advanced oral cancer: Alternative to approach via the superficial temporal artery. Indian J Otolaryngol Head Neck Surg 66(2):205–207Google Scholar
  31. 31.
    Mitsudo K, Koizumi T, Iida M et al (2014) Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases. Radiother Oncol 111:306–310Google Scholar
  32. 32.
    Mitsudo K, Tohnai I, Fujimoto Y et al (2006) Leiomyosarcoma of the maxilla: effective chemotherapy with docetaxel (DOC) and cisplatin (CDDP) using superselective intra-arterial infusion via superficial temporary artery. Oral Oncol Extra 42:258–262CrossRefGoogle Scholar
  33. 33.
    Adachi M, Mitsudo K, Yamamoto N et al (2013) Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery. Head Neck 35:e89–e93CrossRefPubMedGoogle Scholar
  34. 34.
    Mitsudo K, Koizumi T, Iida M et al. (2012) Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases. Int J Radiat Oncol Biol Phys 83:e639-e645Google Scholar
  35. 35.
    Mitsudo K, Koizumi T, Iida M et al (2012) Thermochemoradiotherapy for Oral Cancer with N2, 3 Cervical Lymph Node Metastases using Retrograde Superselective Intra-Arterial Infusion. Themal Med. 28(2):23–28Google Scholar
  36. 36.
    Nishiguchi H, Mitsudo K, Yamamoto N et al (2013) Thermochemoradiotherapy using superselective intra-arterial infusion for N3 cervical lymph node metastases of tongue cancer. J Cancer Res Ther 9(4):718–720Google Scholar

Copyright information

© Springer Japan 2015

Authors and Affiliations

  1. 1.Department of Oral and Maxillofacial SurgeryYokohama City University Graduate School of MedicineYokohamaJapan

Personalised recommendations